for lymphoma (2). In the past decade, we have made significant progress in understanding the biology of acute myeloid leukemia (AML) and ALL, including studying the underlying immune systems at play ...

Adult acute myeloid leukemia treatment (PDQ): health professional version. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;889(9):731-738. Leukemia and ...

The first patient to die was the first patient to try the drug, a 78 year-old man with BPDCN, although the main phase 1 trial is testing the drug in acute myeloid lymphoma. Sourdive said the ...

This invaluable filing allows investors to see what Wall Street's smartest money managers bought and sold in the latest ...

However, concerns around the possibility of high-grade AEs remain, given that Lynparza’s label details the possibility of myelodysplastic syndrome or acute myeloid lymphoma. Another critical ...

The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML ...

Symptoms of non-Hodgkin's lymphoma may include painless swelling ... See what to expect with chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, and learn how it's treated.

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.

Findings suggest the potential for obe-cel treatment without the need for consolidative SCTObe-cel given as a sole treatment to patients with ...

The FDA granted orphan designation to Janssen Research & Development’s bleximenib as a treatment of acute myeloid leukemia, according ...

Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...

AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...